Charles River Laboratories International Inc (NYSE:CRL)
| 250.36 Delayed Data As of Feb 03 |  -9.56 / -3.68%Today’s Change | 181.36 Today|||52-Week Range 349.84 | +14.90% Year-to-Date |
Latest CRL News | Press Releases
| Charles River (CRL) to Report Q4 Earnings: What's in Store? Jan 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 259.92 |
| Today’s open | 250.68 |
| Day’s range | 249.13 - 257.96 |
| Volume | 411,316 |
| Average volume (3 months) | 597,641 |
| Market cap | $13.2B |
Data as of 4:00pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +5.74% |
| Earnings growth (this year) | +5.52% |
| Earnings growth (next 5 years) | +11.74% |
| Revenue growth (last year) | +21.08% |
| P/E ratio | 29.5 |
| Price/Sales | 5.36 |
| Price/Book | 5.18 |
Competitors
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | February 15, 2023 |
| EPS forecast (this quarter) | $2.75 |
| Annual revenue (last year) | $3.5B |
| Annual profit (last year) | $391.0M |
| Net profit margin | 11.04% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Wilmington, Massachusetts |
Forecasts
